ARCHIVES

Letter to the Editor: “We Will Not Be Distracted From Our Mission”

This article is from The Cancer Letter archive.

Vol. 39 No. 05 | February 1, 2013

Download PDF Visit The Full Archive

Related Articles

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Search for New NCI director focuses On California; Possibilities Include Korn, Beahrs, Gale, Others

September 23, 1988

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

DCBDC Board Cool to Proposals On Study Sections

November 23, 1990

NSABP Sees Groups To Join Breast Cancer Prevention Trial

September 27, 1991

Gemcitabine Improves DFS In Resected Pancreatic Cancer

June 24, 2005